The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe

(The Lancet) Failure to get the best treatment and variations in the quality of care are the most likely reasons why survival for blood cancer patients still varies widely between regions within Europe, according to the largest population-based study of survival in European adults to date, published in The Lancet Oncology.